AZZ (AZZ) holder files Rule 144 to sell 2,568 common shares on NYSE
Rhea-AI Filing Summary
AZZ Inc. has a shareholder planning to sell 2,568 shares of common stock under Rule 144. The proposed sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $282,043.44. The filing notes that 29,855,666 shares of this class were outstanding at the time referenced.
The shares to be sold were acquired from the issuer on 05/04/2023 as performance stock units, with the same date listed for payment and the consideration described as N/A, indicating no separate cash purchase price in this notice.
Positive
- None.
Negative
- None.
FAQ
What does the AZZ Rule 144 filing disclose about planned share sales?
The notice shows a shareholder plans to sell 2,568 shares of AZZ common stock under Rule 144 through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $282,043.44.
How many AZZ (AZZ) shares are outstanding in this Rule 144 notice?
The filing reports that 29,855,666 shares of AZZ common stock were outstanding for the class referenced in the planned Rule 144 sale.
How were the AZZ shares being sold under Rule 144 originally acquired?
The 2,568 shares covered by the notice were acquired from the issuer on 05/04/2023 as performance stock units, with the same date listed as the payment date and the nature of payment stated as N/A.
On which exchange will the AZZ Rule 144 shares be sold and through which broker?
The planned sale is listed for the NYSE and is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services.
Does the AZZ Rule 144 notice describe prior sales in the last three months?
The form includes a section for securities sold during the past three months, but in this excerpt no specific prior transactions are listed.
What representation does the selling shareholder make in the AZZ Rule 144 filing?
The person for whose account the securities are to be sold represents that they do not know any material adverse information about AZZ’s current or prospective operations that has not been publicly disclosed.